Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard High Dividend Yield ETF (VYM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard High Dividend Yield ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Vanguard High Dividend Yield ETF trades at $161.5. The key difference: Vanguard High Dividend Yield ETF is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VYM | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $161.17 |
52-Week Low | $23.09 | $132.90 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VYM trades at $161.06, up 0.32% with a bullish technical outlook supported by moving averages. The ETF focuses on high dividend yield stocks, offering income generation through quarterly distributions. Recent news highlights strong investor interest in dividend ETFs for retirement income, with VYM frequently compared to peers like VIG and SCHD for its diversified portfolio and low expense ratio.
The outlook remains positive for income-focused investors, with VYM providing stable dividend payments amid market volatility. Key risks include interest rate sensitivity and economic downturns affecting dividend sustainability. Analyst sentiment is generally favorable, emphasizing its role in balanced portfolios for long-term income generation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard High Dividend Yield ETF
The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →
